CYP cynata therapeutics limited

Ann: CYP-001s FDA Approval Pathway Not Impeded, page-12

  1. 4,849 Posts.
    lightbulb Created with Sketch. 344
    And since you mentioned chatgpt here is the response to are iPSC's safe. I didn't bring chatgpt up by the way, so now I guess you will say they are out of date?

    are ipsc's safe
    ChatGPT said:

    Great question — let’s unpack that carefully.

    Induced pluripotent stem cells (iPSCs) are a type of stem cell created by reprogramming adult somatic cells (like skin or blood cells) to revert them into a pluripotent state, meaning they can differentiate into almost any cell type in the body. They’re hugely valuable for research, drug testing, disease modeling, and regenerative medicine.

    As for safety — it depends on the context of their use.
    Here’s a breakdown:

    ✅ iPSC Safety Positives:

    • Ethically preferable: No embryos are destroyed to create them.

    • Patient-specific potential: You can generate iPSCs from a patient’s own cells, minimizing the risk of immune rejection.

    • Lab research & disease modeling: In vitro uses are considered safe.

    ⚠️ iPSC Safety Concerns:

    • Genetic instability: The reprogramming process can introduce genetic mutations or epigenetic abnormalities.

    • Tumorigenicity: Like embryonic stem cells, iPSCs can form teratomas (benign tumors of mixed tissue) if undifferentiated cells are transplanted.

    • Reprogramming factors: Traditional methods used viral vectors to introduce genes like c-Myc, which is oncogenic (cancer-promoting). Newer, safer techniques (non-integrating methods like episomal vectors, mRNA, or CRISPR-based systems) reduce this risk but aren’t entirely risk-free.

    • Incomplete differentiation: If cells aren’t fully or correctly differentiated before transplantation, unintended effects can occur.

    Current Status:

    • In lab and preclinical contexts, they’re widely used and relatively safe.

    • In clinical trials (there are a handful ongoing globally — e.g., for macular degeneration, Parkinson’s), safety is still being rigorously tested.

    • Regulatory authorities like the FDA or EMA closely oversee any therapeutic use.

    In summary:
    Safe in lab research.
    ⚠️ Potential risks for clinical applications — being actively addressed through better reprogramming, differentiation, and screening techniques.






 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
-0.010(5.56%)
Mkt cap ! $38.41M
Open High Low Value Volume
17.0¢ 17.0¢ 16.5¢ $21.40K 127.0K

Buyers (Bids)

No. Vol. Price($)
9 425750 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 90178 3
View Market Depth
Last trade - 14.06pm 13/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.